A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

Clinical trial NCT07345494 · RECRUITING

Trial details

NCT number: NCT07345494
Sponsor: Ascendis Pharma A/S
Status: RECRUITING
Study type: OBSERVATIONAL

Hypoparathyroidism

Start date: 2026-02-18
Primary completion: 2036-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.